AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kraig Biocraft Laboratories, Inc.

$0.08 -$0.01 (-6.10%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.08
Day Range
$0.08$0.09
Year Range
$0.07$0.16
Market Cap
89.04M
AVG Volume
847.53K
Trailing/Forward PE
-21.05/-
PEG ratio
0.47
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0200B400B600B2016201720182019202020212022202320242025
KBLB Revenue (USD) by year
PeriodRevenue (USD)
20250
202426.92K
202340.08K
20220
20210
20200
20190
2018401.62B
201797.32K
201631.86K
Net Income (USD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
KBLB Net Income (USD) by year
PeriodNet Income (USD)
2025-3.62M
2024-3.4M
2023-3.03M
2022-3.84M
2021-8.05M
2020-4.97M
2019-2.91M
2018-1.17M
2017-2.33M
2016-3.07M
Operating Income (USD)
-6M-4M-2M02016201720182019202020212022202320242025
KBLB Operating Income (USD) by year
PeriodOperating Income (USD)
2025-3.37M
2024-3.07M
2023-2.62M
2022-2.12M
2021-2.76M
2020-4.53M
2019-2.62M
2018-961K
2017-2.16M
2016-2.95M
EBITDA (USD)
-8M-6M-4M-2M02016201720182019202020212022202320242025
KBLB EBITDA (USD) by year
PeriodEBITDA (USD)
2025-3.03M
2024-2.84M
2023-2.52M
2022-3.2M
2021-7.36M
2020-4.51M
2019-2.58M
2018-913K
2017-2.14M
2016-2.92M
Cash Flows (USD)
-2T-1.5T-1T-500B02016201720182019202020212022202320242025
KBLB Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-1.79T
2024-2.35M
2023-1.24M
2022-1.89M
2021-1.89M
2020-1.25M
2019-1.19M
2018-11.45B
2017-760.71K
2016-2.49B
EPS (USD)
-0.01-0.01-0-002016201720182019202020212022202320242025
KBLB EPS (USD) by year
PeriodEPS (USD)
2025-0
2024-0
2023-0
2022-0
2021-0.01
2020-0.01
2019-0
2018-0
2017-0
2016-0
Expenses (USD)
01T2T3TR&DSG&ACapex2016201720182019202020212022202320242025
KBLB Expenses (USD) by year
PeriodExpenses (USD)
20252.51T
20243.08M
20232.44M
20222.13M
20212.85M
20204.53M
20192.72M
201811.45B
20172.28M
20162.49B
Cash & Debt (USD)
050B100B150BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
KBLB Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20251.79M
2024673.26K
20232.55M
20223.86M
20212.36M
2020816.91K
2019125.02K
201813.7K
201718.15K
2016298.86K
Debt ratios
-0.2-0.100.10.220182019202020212022202320242025
KBLB Debt ratios by year
PeriodDebt ratios
20250.01
2024-0.06
20230.05
20220.12
2021-0
2020-0.15
2019-0.15
2018-0.04
Margins
-100%-50%0%50%100%20162017201820232024
KBLB Margins by year
PeriodMargins
2024-24.7%
2023-68.91%
2018100%
201792.11%
2016100%
Return on Capital
0%50%100%150%200%2016201720182019202020212022202320242025
KBLB Return on Capital by year
PeriodReturn on Capital
202545.3%
202441.7%
202353.08%
2022109.09%
2021151.93%
202075.62%
201954%
201826.22%
201769.12%
2016130.18%
Shares Outstanding
0500M1B1.5B2016201720182019202020212022202320242025
KBLB Shares Outstanding by year
PeriodShares Outstanding
20251.06B
20241.04B
20231.04B
2022975.45M
2021879.56M
2020844.47M
2019844.57M
2018816.88M
2017802.96M
2016772.26M
Book Value Per Share (USD)
-0.01-0.01-0-002016201720182019202020212022202320242025
KBLB Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-0.01
2024-0.01
2023-0.01
2022-0
2021-0.01
2020-0.01
2019-0.01
2018-0.01
2017-0
2016-0
Total Assets (USD)
02M4M6M2016201720182019202020212022202320242025
KBLB Total Assets (USD) by year
PeriodTotal Assets (USD)
20252.57M
20241.51M
20233.23M
20224.57M
20213.02M
20201.28M
2019750.85K
201871.38K
2017114.5K
2016383.66K
Employee Count
02.557.5102014201520162017201820192020
KBLB Employee Count by year
PeriodEmployee Count
20207
20195
20189
20177
20165
20152
20142
Free Cash Flow Yield
-3000000%-2000000%-1000000%0%med -2.51%Jan 25May 25Sep 25Jan 26May 26Sep 26
KBLB Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-2020057.33%
Sep 26-1979478.03%
Sep 26-2011383.24%
Aug 26-1890112.12%
Aug 26-1737683.72%
Aug 26-1835477.15%
Aug 26-1753619.23%
Jul 26-1718803.38%
Jul 26-1888513.01%
Jul 26-1659833.34%
Jul 26-1612642%
Jul 26-1483223.48%
Jun 26-1569556.14%
Jun 26-1495358.94%
Jun 26-1480286.93%
Jun 26-1370745.7%
May 26-1349380.5%
May 26-1266277.78%
May 26-1218440.62%
May 26-1184348.54%
May 26-1119377.67%
Apr 26-1138567%
Apr 26-1177104.82%
Apr 26-1230827.34%
Apr 26-1505974.05%
Mar 26-1.46%
Mar 26-1.5%
Mar 26-1.39%
Mar 26-1.28%
Feb 26-1.24%
Feb 26-1.62%
Feb 26-2.16%
Feb 26-2.18%
Jan 26-2.15%
Jan 26-2.1%
Jan 26-2.02%
Jan 26-2.13%
Jan 26-2.04%
Dec 25-2.07%
Dec 25-2.1%
Dec 25-2.05%
Dec 25-2.04%
Nov 25-1.96%
Nov 25-2.05%
Nov 25-2.07%
Nov 25-2.31%
Oct 25-2.44%
Oct 25-2.37%
Oct 25-2.4%
Oct 25-2.33%
Oct 25-2.4%
Sep 25-2.06%
Sep 25-2.48%
Sep 25-2.56%
Sep 25-2.58%
Aug 25-2.67%
Aug 25-2.67%
Aug 25-2.67%
Aug 25-2.66%
Aug 25-2.72%
Jul 25-2.68%
Jul 25-2.7%
Jul 25-2.53%
Jul 25-2.69%
Jun 25-2.69%
Jun 25-2.6%
Jun 25-2.6%
Jun 25-2.5%
May 25-2.77%
May 25-2.66%
May 25-2.58%
May 25-2.55%
May 25-2.47%
Apr 25-2.64%
Apr 25-2.52%
Apr 25-2.6%
Apr 25-2.64%
Mar 25-2.74%
Mar 25-2.48%
Mar 25-2.57%
Mar 25-2.73%
Feb 25-2.38%
Feb 25-2.23%
Feb 25-2.17%
Feb 25-2.16%
Jan 25-2.21%
Jan 25-2.15%
Jan 25-2.25%
Jan 25-2.1%
Jan 25-2.13%
Dec 24-2.12%
Dec 24-2.31%
Dec 24-2.18%
Dec 24-1.84%
Nov 24-2.32%
Nov 24-2.39%
Nov 24-2.24%
Nov 24-1.6%
Nov 24-1.68%
Oct 24-1.65%
Price to Sales
100020003000400050006000med 3202.99Jul 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
KBLB Price to Sales by year
PeriodPrice to Sales
Mar 264730.56
Mar 264602.77
Mar 264976.61
Mar 265377.44
Feb 265559.99
Feb 264266.23
Feb 263194.71
Feb 263174.87
Jan 263214.56
Jan 263296.9
Jan 263416.16
Jan 263246.3
Jan 263381.24
Dec 253337.58
Dec 253293.93
Dec 253377.27
Dec 253389.17
Nov 253532.04
Nov 253373.3
Nov 253330.64
Nov 253595.67
Oct 253405
Oct 253498.39
Oct 253457.14
Oct 253560.65
Oct 253463.37
Sep 254035.41
Sep 253350.52
Sep 253245.45
Sep 253220.15
Aug 253113.14
Aug 253113.14
Aug 253113.14
Aug 253211.27
Aug 253141.63
Jul 253191.93
Jul 253159.43
Jul 253381.51
Jul 253172.58
Jun 253180.32
Jun 253284.78
Jun 253288.65
Jun 253420.2
May 253087.46
May 253211.27
May 253311.87
May 253433.22
May 253545.08
Apr 253317.49
Apr 253471.79
Apr 253359.92
Apr 253318.65
Mar 253190.19
Mar 252176.02
Mar 252098.3
Mar 251980.43
Feb 252266.68
Feb 252422.11
Feb 252486.88
Feb 252499.83
Jan 252445.43
Jan 252515.37
Jan 252396.21
Jan 252575.6
Jan 252538.69
Dec 242550.47
Dec 242333.91
Dec 242478.07
Dec 242940.21
Nov 242331.45
Nov 242258.91
Nov 242409.16
Nov 242460.97
Nov 242339.22
Oct 242389.73
Oct 242313.31
Oct 242201.92
Oct 242383.26
Sep 242252.44
Sep 242358.65
Sep 242396.21
Sep 242317.46
Aug 242519.26
Aug 242526.25
Aug 242533.5
Aug 242935.03
Aug 242694.11
Jul 242940.21
Jul 243160.4
Jul 243414.27
Jul 243626.69
Jun 243315.83
Jun 243885.74
Jun 243648.97
Jun 243419.45
May 243251.07
May 242810.69
May 243323.61
May 243491.99
May 242409.16
Kraig Biocraft Laboratories, Inc.
KBLB
Stockpicker

Video analysis: KBLB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KBLB

As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers

globenewswire.com · 14 Sep 2026

As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers

ANN ARBOR, Mich., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today highlighted the growing opportunity for advanced biomaterials in fashion as New York Fashion Week begins.

Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality

globenewswire.com · 3 Sep 2026

Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality

Kraig Labs (OTCQB:KBLB) featured in Tech Times examining the scientific gap between fictional biology and real-world advances in spider silk production.

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

globenewswire.com · 24 Aug 2026

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

Kraig Labs (OTCQB: KBLB) set another spider silk production record, over 30% more than its previous record levels, even during the difficult rainy season

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

globenewswire.com · 10 Aug 2026

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

Kraig Labs (OTCQB: KBLB) CEO published a thought leadership scientific opinion editorial in Biocompare, serving the life sciences and biotech research comm

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

globenewswire.com · 21 Jul 2026

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Kraig Labs (OTCQB: KBLB) CEO and Founder featured in an in-depth interview published by Just Style, a leading global apparel and textile industry trade pub

Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

globenewswire.com · 10 Jul 2026

Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

Kraig Labs (OTCQB: KBLB) CEO and Founder is featured in Authority Magazine's "Meet the Disruptors" series, a widely read publication on the Medium platform

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

globenewswire.com · 15 Jun 2026

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Kraig Labs (OTCQB: KBLB) CEO featured in an extensive interview with Pulse 2.0, where he discussed the Company's technological leadership, commercial produ

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.